On Wednesday, December 10th, Bristol-Myers Squibb Company (BMY) announced a quarterly dividend increase from $0.62 to $0.63 per share that’s payable February 2, 2026 to holders of record January 2, 2026. This represents a 1.61% increase over the last quarterly dividend.
This marks the 17th consecutive year that the company has increased its dividend and the 94th consecutive year that the company has paid a dividend.
At the current price of $54.23 (yesterday's close), this increase will raise BMY's dividend yield to 4.65%.
Bristol-Myers Squibb is a Dividend Contenders with a 16 year streak of dividend increases. Dividend growth rates for 1, 3, 5 and 10 years are 5.3, 7.0, 7.9 and 5.2 (Dividend Champions.xls)
As an owner of 120 shares of BMY, the recent dividend increase adds $3.58 to my projected annual net dividend income.
I was expecting dividend increase of two-cent, so this was half of that, but an increase is always an increase and better than nothing.
This marks the fifth dividend increase I’ve received from Bristol-Myers Squibb since initiating my position in December 2020. During that time, the company’s quarterly dividend has increased moderately from $0.49 to $0.63 per share — a cumulative increase of 28.6%.
As of this writing, BMY represents approximately 0.73% of my portfolio by weight and contributes around 0.82% to my projected annual dividend income.
Following this increase, my yield on cost is 4.58%.
Summary of 2025 Dividend Increases / Cuts
Click here to see my portfolio holdings.
You can follow the development of my dividends here.
Full Disclosure: Long BMY
Thanks for stopping by!
No comments:
Post a Comment